Allianz Asset Management GmbH Has $17.20 Million Stock Position in DENTSPLY SIRONA Inc. $XRAY

Allianz Asset Management GmbH raised its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 63.6% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,355,643 shares of the medical instruments supplier’s stock after purchasing an additional 526,973 shares during the quarter. Allianz Asset Management GmbH owned approximately 0.68% of DENTSPLY SIRONA worth $17,203,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in the stock. Mitsubishi UFJ Trust & Banking Corp increased its stake in DENTSPLY SIRONA by 1,836.7% in the third quarter. Mitsubishi UFJ Trust & Banking Corp now owns 105,938 shares of the medical instruments supplier’s stock valued at $1,344,000 after acquiring an additional 100,468 shares during the last quarter. Bank of Montreal Can boosted its holdings in shares of DENTSPLY SIRONA by 8.2% in the 2nd quarter. Bank of Montreal Can now owns 352,524 shares of the medical instruments supplier’s stock valued at $5,598,000 after purchasing an additional 26,610 shares in the last quarter. Commonwealth Equity Services LLC boosted its holdings in shares of DENTSPLY SIRONA by 38.4% in the 3rd quarter. Commonwealth Equity Services LLC now owns 804,934 shares of the medical instruments supplier’s stock valued at $10,215,000 after purchasing an additional 223,339 shares in the last quarter. CWM LLC increased its stake in shares of DENTSPLY SIRONA by 84.3% in the 3rd quarter. CWM LLC now owns 420,470 shares of the medical instruments supplier’s stock valued at $5,336,000 after purchasing an additional 192,373 shares during the last quarter. Finally, Nordea Investment Management AB raised its holdings in shares of DENTSPLY SIRONA by 33.3% during the 3rd quarter. Nordea Investment Management AB now owns 570,466 shares of the medical instruments supplier’s stock worth $7,194,000 after buying an additional 142,451 shares in the last quarter. Institutional investors and hedge funds own 95.70% of the company’s stock.

DENTSPLY SIRONA Stock Performance

Shares of DENTSPLY SIRONA stock opened at $13.76 on Friday. The stock has a market cap of $2.74 billion, a price-to-earnings ratio of -3.11, a P/E/G ratio of 1.11 and a beta of 1.01. DENTSPLY SIRONA Inc. has a twelve month low of $9.85 and a twelve month high of $19.27. The company’s fifty day moving average is $11.90 and its 200 day moving average is $12.65. The company has a quick ratio of 0.99, a current ratio of 1.47 and a debt-to-equity ratio of 1.36.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its earnings results on Thursday, November 6th. The medical instruments supplier reported $0.37 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.45 by ($0.08). The firm had revenue of $904.00 million during the quarter, compared to analyst estimates of $900.33 million. DENTSPLY SIRONA had a negative net margin of 24.34% and a positive return on equity of 17.10%. DENTSPLY SIRONA’s quarterly revenue was down 4.9% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.50 EPS. Sell-side analysts forecast that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current year.

DENTSPLY SIRONA Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, January 9th. Stockholders of record on Friday, December 26th were given a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a dividend yield of 4.7%. The ex-dividend date of this dividend was Friday, December 26th. DENTSPLY SIRONA’s dividend payout ratio is -14.48%.

Analyst Ratings Changes

A number of research firms recently issued reports on XRAY. Barclays started coverage on shares of DENTSPLY SIRONA in a research report on Monday, December 8th. They set an “underweight” rating and a $12.00 price objective for the company. Wells Fargo & Company decreased their target price on shares of DENTSPLY SIRONA from $15.00 to $12.00 and set an “equal weight” rating on the stock in a research note on Friday, November 7th. Zacks Research downgraded shares of DENTSPLY SIRONA from a “hold” rating to a “strong sell” rating in a report on Monday, November 10th. Barrington Research reissued an “outperform” rating and set a $14.00 price objective on shares of DENTSPLY SIRONA in a report on Monday, January 5th. Finally, Mizuho boosted their price objective on DENTSPLY SIRONA from $13.00 to $14.00 and gave the stock a “neutral” rating in a research report on Tuesday, January 20th. Two analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have given a Sell rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Reduce” and an average price target of $14.25.

Insider Activity at DENTSPLY SIRONA

In related news, Director Gregory T. Lucier sold 82,200 shares of the business’s stock in a transaction dated Monday, December 8th. The stock was sold at an average price of $11.14, for a total value of $915,708.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 0.50% of the stock is currently owned by corporate insiders.

DENTSPLY SIRONA Company Profile

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.